Coronavirus: Ohio tests nitric oxide treatment


The Ohio State University Wexner Medical Centre has launched a new clinical trial that uses inhaled nitric oxide to treat coronavirus patients.

Researchers are administrating continuously pulsed inhaled nitric oxide via a Bellerophon INOpulse® delivery system to prevent the progression of the virus in patients with mild to moderate coronavirus-related pneumonia.

The targeted treatment is given to patients who require oxygen but before a ventilator is needed to support breathing.

“There’s a greater likelihood of death among COVID-19 patients with pneumonia who are placed on a ventilator,” said Dr. Sitaramesh Emani, Principal Investigator, Cardiologist at The Ohio State University Wexner Medical Centre.

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Please wait...